Clinical Trial Update: Dapagliflozin in Systemic Right Ventricle (DAPA-SERVE) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating dapagliflozin for patients with systemic right ventricle, focusing on adverse reactions and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Right Ventricle

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Monaldi Hospital | Conditions: Dapagliflozin Adverse Reaction, Efficacy | Phase 4 | Status: UNKNOWN